Benitec Biopharma (BNTC) Asset Utilization Ratio (2020 - 2024)
Benitec Biopharma (BNTC) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.0 as the latest value for Q1 2024.
- Quarterly Asset Utilization Ratio fell 94.3% to 0.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 0.0 through Mar 2024, down 94.3% year-over-year, with the annual reading at 0.01 for FY2023, 169.25% up from the prior year.
- Asset Utilization Ratio hit 0.0 in Q1 2024 for Benitec Biopharma, down from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.01 in Q3 2020 to a low of 0.0 in Q3 2021.
- Historically, Asset Utilization Ratio has averaged 0.0 across 5 years, with a median of 0.0 in 2022.
- Biggest five-year swings in Asset Utilization Ratio: plummeted 98.33% in 2021 and later surged 2871.08% in 2022.
- Year by year, Asset Utilization Ratio stood at 0.0 in 2020, then plummeted by 56.17% to 0.0 in 2021, then soared by 134.93% to 0.0 in 2022, then crashed by 38.98% to 0.0 in 2023, then crashed by 84.72% to 0.0 in 2024.
- Business Quant data shows Asset Utilization Ratio for BNTC at 0.0 in Q1 2024, 0.0 in Q4 2023, and 0.0 in Q3 2023.